In most previous studies, LINGO-1 antibody effects on remyelination in EAE mouse models of MS have been investigated (21,30,31) and the only study using the cuprizone model to evaluate the LINGO-1 antibody effects on remyelination was performed by Sun et al. in 2016 (22). Here, LINGO1 is linked to myeloid sarcoma.